Cargando…
重组人血管内皮抑素联合化疗与单纯化疗在晚期非小细胞肺癌中疗效比较的系统评价
BACKGROUND AND OBJECTIVE: In recent years, there has been a large number of studies and reports about the efficacy and safety of recombinant human endostatin (rh-endostatin), an anti-angiogenic drug, in treatment of advanced lung cancer. Authentic assessment of rh-endostatin treatment in lung cancer...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000328/ https://www.ncbi.nlm.nih.gov/pubmed/21569645 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.05.05 |